ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,322.50
0.27%
Dow Jones
39,889.70
0.21%
US Dollar vs MXN
16.6304
0.45%
Brent Oil
82.745
-0.94%
Bitcoin
69,453.12
-2.79%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Micro Therapeutics (MM) (MTIX)

  7. Micro Therapeutics (MM) (MTIX) Noticias

MTIX

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MTIX
FechaHoraFuenteTítuloSímboloCompañía
08/12/200510:01PR Newswire (US)ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
14/11/200508:11PR Newswire (US)ev3 Inc. and Micro Therapeutics, Inc. Announce Merger AgreementNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200508:01PR Newswire (US)Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net SalesNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200508:00PR Newswire (US)ev3 Inc. Reports Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
21/10/200509:00PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005NASDAQ:MTIXMicro Therapeutics (MM)
10/10/200509:30PR Newswire (US)ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
10/10/200508:30PR Newswire (US)Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.NASDAQ:MTIXMicro Therapeutics (MM)
05/10/200513:04PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
02/08/200516:51PR Newswire (US)Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005NASDAQ:MTIXMicro Therapeutics (MM)
02/08/200516:48PR Newswire (US)ev3 Inc. Reports Second Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
27/07/200515:27PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005NASDAQ:MTIXMicro Therapeutics (MM)
21/07/200517:27PR Newswire (US)ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
21/07/200517:08PR Newswire (US)Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
06/07/200517:30PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
28/04/200516:14PR Newswire (US)Micro Therapeutics Reports 50% Net Sales Increase for 2005 First QuarterNASDAQ:MTIXMicro Therapeutics (MM)
25/04/200512:28PR Newswire (US)Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005NASDAQ:MTIXMicro Therapeutics (MM)
21/03/200515:57PR Newswire (US)ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
10/02/200514:23PR Newswire (US)Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
10/02/200506:45PR Newswire (US)Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on FebruaryNASDAQ:MTIXMicro Therapeutics (MM)
07/02/200517:40PR Newswire (US)Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005NASDAQ:MTIXMicro Therapeutics (MM)
01/02/200506:00PR Newswire (US)Micro Therapeutics Receives $3.7 Million PaymentNASDAQ:MTIXMicro Therapeutics (MM)
29/12/200411:13PR Newswire (US)Micro Therapeutics Consolidates Manufacturing CapabilitiesNASDAQ:MTIXMicro Therapeutics (MM)
06/12/200414:04PR Newswire (US)ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
10/11/200408:00PR Newswire (US)ev3 International Files Lawsuit Against Distributors in Hong Kong and PhoenixNASDAQ:MTIXMicro Therapeutics (MM)
04/11/200406:00PR Newswire (US)Micro Therapeutics Reports 2004 Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
01/11/200414:24PR Newswire (US)Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4NASDAQ:MTIXMicro Therapeutics (MM)
21/10/200410:47PR Newswire (US)FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long StentsNASDAQ:MTIXMicro Therapeutics (MM)
21/09/200408:01PR Newswire (US)ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft UseNASDAQ:MTIXMicro Therapeutics (MM)
26/08/200411:33PR Newswire (US)ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting ProceduresNASDAQ:MTIXMicro Therapeutics (MM)
18/08/200412:51PR Newswire (US)Micro Therapeutics Completes Issuance of Common Stock for Exchangeable NotesNASDAQ:MTIXMicro Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:MTIX

Su Consulta Reciente

NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
OILBRENT
Brent Oil
NYSE
MRK
Merck
NYSE
KO
Coca Cola
USOTC
BNPQY
BNP Paribas (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados